Biotech - Spark Newswire

3 minute read

CENTOGENE Announces Investor Event Jun. 22 At 9:00 a.m. EDT

Today, 7:16 PM

Company outlines significant value creation potential to contribute to the diagnosis of rare diseases and to enable the development of novel therapeutics Focuses on leveraging its unique rare disease-centric

CNTG

1 minute read

Sanofi, Translate Bio Initiate Early-Stage mRNA Influenza Vaccine Trial

By Vandana Singh

Today, 7:16 PM

Sanofi Pasteur, vaccine unit of Sanofi SA (NASDAQ:SNY) and Translate Bio Inc (NASDAQ:TBIO) have initiated a Phase 1 trial evaluating an mRNA-based investigational vaccine…

SNY

1 minute read

GSK- Pfizer’s ViiV To Develop ‘Ultra-Long-Acting’ HIV Drugs With $215M Halozyme Deal

By Vandana Singh

Today, 7:16 PM

GlaxoSmithKline plc (NYSE:GSK), Pfizer Inc (NYSE:PFE), and Shionogi Limited owned ViiV Healthcare has collaborated with Halozyme Therapeutics Inc (NASDAQ:HALO) to gain access to Halozyme’s Enhanze drug delivery…

GSK

2 minute read

Nevro Announces Presentation Of SENZA-NSRBP Clinical Data At American Society Of Interventional Pain Physicians 23rd Annual Meeting Jun. 24-26

By Bill Haddad

Today, 7:16 PM

PRNewswire/ -- Nevro Corp. (NYSE:NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that data from the SENZA

NVRO

2 minute read

NanoString Launches nCounter Stem Cell Characterization Panel To ‘Advance the Development of Stem Cell Therapy’

By Bill Haddad

Today, 7:16 PM

NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® Stem Cell Characterization Panel for the

NSTG

1 minute read

Fennec Pharmaceuticals Announces FDA Acceptance Of New Drug Application Resubmission For PEDMARK

By Bill Haddad

Today, 7:16 PM

Fennec Pharmaceuticals Inc. (NASDAQ:FENC, TSX:FRX), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the resubmission of its New Drug

FENC

2 minute read

Technical Levels To Watch In Aytu BioPharma Stock

By Tyler Bundy

Today, 7:16 PM

Aytu BioPharma Inc. (NASDAQ: AYTU) shares were rallying Monday after retail traders were able to push the stock higher.

AYTU

2 minute read

Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries

By Vandana Singh

Today, 7:16 PM

Moderna Inc (NASDAQ:MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19…

MRNA

1 minute read

GlaxoSmithKline CEO Struggling To Get Key Shareholders In Her Favor Amid Pressure From Hedge Fund Activist Elliott Management

By Vandana Singh

Today, 7:16 PM

GlaxoSmithKline Plc’s (NYSE:GSK) CEO Emma Walmsley struggled to win over key shareholders after Elliott Management attracted converts for radical…

GSK

1 minute read

Cassava Sciences Stock Gains After Outlining Clinical Development Progress For Lead Alzheimer’s Candidate

By Vandana Singh

Today, 7:16 PM

Cassava Sciences Inc (NASDAQ:SAVA) has announced a mid-year update highlighting clinical development progress and providing guidance on upcoming data releases for…

SAVA